MAAT PHARMA SACA (MAAT.PA) Stock Cash Flow
EPA:MAAT • FR0012634822
7.64 EUR
+0.08 (+1.06%)
Last: Feb 18, 2026, 07:00 PM
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -31.13M | -28.90M | -19.72M | -13.71M | -9.02M | |||
| Depreciation Amortization | 1.73M | 1.69M | 871.00K | 429.00K | 328.00K | |||
| Change In Working Capital | 2.69M | 3.38M | -384.00K | -50.00K | -208.00K | |||
| Interest Paid | 454.00K | 485.00K | 179.00K | 151.00K | 97.00K | |||
| Other non cash items | 2.04M | 1.79M | 561.00K | 728.00K | 971.00K | |||
| OPERATING CASH FLOW | -24.24M | -22.04M | -18.67M | -12.61M | -7.93M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -782.00K | -753.00K | -1.09M | -662.00K | -238.00K | |||
| Other Investing Activity | 296.00K | 337.00K | 653.00K | -153.00K | 0.00 | |||
| INVESTING CASH FLOW | -496.00K | -416.00K | -440.00K | -815.00K | -238.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -3.53M | 1.54M | -4.19M | 5.55M | -485.00K | |||
| Stock Issued/Repurchased | 12.06M | 17.26M | 12.51M | -35.00K | 32.44M | |||
| Other Financing Activity | 447.00K | -468.00K | -179.00K | -151.00K | -392.00K | |||
| FINANCING CASH FLOW | 8.26M | 18.33M | 8.14M | 5.36M | 31.56M | |||
| CHANGE IN CASH | -16.48M | -4.13M | -10.97M | -8.06M | 23.39M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -24.24M | -22.04M | -18.67M | -12.61M | -7.93M | |||
| Capital Expenditure | -782.00K | -753.00K | -1.09M | -662.00K | -238.00K | |||
| FREE CASH FLOW | -25.02M | -22.79M | -19.76M | -13.27M | -8.17M | |||
All data in EUR